RGC

Dollar change -0.36
Percentage change -2.42	%

Peers: NVS JNJ ABBV PFE MRK LLY BMY AZN NVO GSK

Index	-	P/E	-	EPS (ttm)	-0.31	Insider Own	96.15%	Shs Outstand	494.49M	Perf Week	-1.69%
Market Cap	7.17B	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	19.01M	Perf Month	-81.41%
Enterprise Value	7.16B	PEG	-	EPS next Q	-	Inst Own	0.07%	Short Float	6.50%	Perf Quarter	1922.02%
Income	-4.09M	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	0.41	Perf Half Y	11284.30%
Sales	0.00M	P/B	28.10	EPS next Y	-	ROA	-45.55%	Short Interest	1.23M	Perf YTD	11053.85%
Book/sh	0.52	P/C	900.77	EPS next 5Y	-	ROE	-48.45%	52W High	83.60 -82.66%	Perf Year	16347.76%
Cash/sh	0.02	P/FCF	-	EPS past 3/5Y	-45.88% -60.65%	ROIC	-60.89%	52W Low	0.08 18084.82%	Perf 3Y	2008.69%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	12.67% 36.17%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	13.20%	Oper. Margin	-	ATR (14)	6.10	Perf 10Y	-
Dividend Ex-Date	Feb 15, 2018	Quick Ratio	41.92	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	45.47	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	41.92	EPS Q/Q	10.33%	SMA20	-21.29%	Beta	2.24	Target Price	-
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-22.57%	Rel Volume	0.21	Prev Close	14.86
Employees	12	LT Debt/Eq	0.00	Earnings	-	SMA200	192.95%	Avg Volume	2.98M	Price	14.50
IPO	Jul 16, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	- -	Trades		Volume	638,599	Change	-2.42%

Jul-17-25 03:51PM	Regencell Bioscience (RGC) Insanely Up Over 11,000% in H1 (Insider Monkey)
Jul-08-25 02:26PM	Regencell Bioscience (RGC) Nosedives 19.8% on Profit-Taking (Insider Monkey)
Jul-07-25 10:34AM	Regencell Bioscience Stock Volatility Continues Monday (Investopedia) -19.83%
Jul-01-25 03:51AM	1 Magnificent Stock-Split Stock to Buy Hand Over Fist in July and 1 to Completely Avoid (Motley Fool) -14.32%
Jun-30-25 04:03PM	Trading in risky penny stocks is booming. Why it could be a sign of trouble ahead for the market. (MarketWatch)
12:05PM	Loading…
Jun-27-25 12:05PM	Regencell's 82,000% Surge: The $33 Billion Stock Rally That Nobody Can Explain (GuruFocus.com) -13.82%
05:18AM	Mystery $33 Billion Medicine Fortune Collapses in Days (Bloomberg)
Jun-20-25 03:06AM	Prediction: Wall Street's Latest Stock-Split Stock -- Up 60,120% Year-to-Date -- Is Going to Implode... It's Just a Matter of Time (Motley Fool) -40.00%
Jun-17-25 12:43PM	The 46,000% Biotech Rocket: How a No-Revenue Stock Hit $30 Billion (GuruFocus.com) +30.00%
12:25PM	Silver's rise, Reddit's AI ad tools, Regencell Bioscience surges (Yahoo Finance Video)
Jun-16-25 04:30PM	Herbal Medicine Stock With No Sales Rallies 64,000% (Bloomberg) +283.13%
11:00AM	Regencell Bioscience Stock Skyrockets as 38-to-1 Split Takes Effect (Investopedia)
Apr-30-25 06:01AM	Why Regencell Bioscience Holdings Limited (RGC) is Surging in 2025 (Insider Monkey) +89.87%
Mar-22-25 11:00AM	Investors To Focus On PCE Price Index Print As Cintas, Lululemon To Report Earnings (SeekingAlpha)
Mar-21-25 06:35AM	Why Regencell Bioscience Holdings Ltd. (RGC) Surged On Thursday? (InsiderMonkey) +30.29%
07:28AM	Loading…
Mar-17-25 07:28AM	Why Regencell Bioscience Holdings Limited (RGC) Soared Last Week? (Insider Monkey) +46.59%
Jul-23-24 04:02PM	What Is Going on With Regencell Bioscience (RGC) Stock Today? (InvestorPlace) +343.92% -9.76%
Nov-15-23 04:31PM	15 Developed Countries with Lowest Autism Rates (Insider Monkey) +11.11%
Jul-31-23 08:15AM	With 81% ownership, Regencell Bioscience Holdings Limited (NASDAQ:RGC) insiders have a lot riding on the company's future (Simply Wall St.)
Apr-03-23 07:25AM	One Regencell Bioscience Holdings Limited (NASDAQ:RGC) insider upped their stake by 0.5% in the previous year (Simply Wall St.)
Feb-21-23 06:36AM	With 81% ownership, Regencell Bioscience Holdings Limited (NASDAQ:RGC) insiders have a lot riding on the company's future (Simply Wall St.) -5.99%
Nov-21-22 06:49AM	Companies Like Regencell Bioscience Holdings (NASDAQ:RGC) Are In A Position To Invest In Growth (Simply Wall St.)
Nov-15-22 07:55AM	RGC: Forging a New Approach to ADHD and ASD (Zacks Small Cap Research)
Oct-25-22 06:55AM	One Regencell Bioscience Holdings Limited (NASDAQ:RGC) insider upped their stake by 1.4% in the previous year (Simply Wall St.)
Sep-14-22 06:55AM	81% of Regencell Bioscience Holdings Limited (NASDAQ:RGC) is owned by insiders, and they've been buying recently (Simply Wall St.)
Sep-12-22 09:15AM	Regencell Biosciences Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy Trial (Business Wire)
Jun-20-22 05:27AM	RGC: CEO Figuratively Putting His Money Where His Mouth Is (Zacks Small Cap Research)
May-24-22 05:46AM	RGC: Second investigational study of RGC-COV19 replicates results of earlier trial in eliminating COVID-19 symptoms. (Zacks Small Cap Research)
May-18-22 08:05AM	Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period (Business Wire)
06:14AM	The Founder of Regencell Bioscience Holdings Limited (NASDAQ:RGC), Yat-Gai Au, Just Bought A Few More Shares (Simply Wall St.)
08:56AM	Loading…
May-16-22 08:56AM	Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO (Business Wire)
Apr-14-22 10:03AM	RGC: Regencell Bioscience - Investigational Liquid-Formula RGC-COV19 Shows Promise in Eliminating COVID-19 Symptoms (Zacks Small Cap Research)
Apr-07-22 06:09AM	What Is The Ownership Structure Like For Regencell Bioscience Holdings Limited (NASDAQ:RGC)? (Simply Wall St.) +9.34%
Mar-01-22 08:30AM	Regencell Describes Their Traditional Chinese Medicine ("TCM") Treatments and Recent Efficacy Trial Results in New Video Interview on SNN Network (ACCESSWIRE)
Feb-17-22 11:40AM	Regencell Bioscience's COVID-19 Candidate Shows Encouraging Action On Mild To Moderate Symptoms (Benzinga) +14.45%
Feb-16-22 08:42PM	Regencell Biosciences Investigational Liquid-Formula RGC-COV19TM Shows Effectiveness Through Its Enrolled Patients in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-day Treatment Period in its EARTH Efficacy Trial (Business Wire)
Dec-13-21 08:35AM	Regencell Bioscience Holdings Limited Appoints Dr. William Wing-Yan Lo, JP to its Board of Directors (Business Wire)
Nov-22-21 08:15AM	Regencell Bioscience Holdings Limited Announces Over $1 Million Ordinary Share Purchase by CEO (Business Wire)
08:00AM	Regencell Bioscience Holdings Limited Included in the MSCI World Micro Cap Index (Business Wire)
Nov-02-21 04:00AM	RGC: Traditional Chinese Medicine Approach for treatment of neurodevelopmental conditions (Zacks Small Cap Research)
Oct-19-21 11:44AM	Do Institutions Own Regencell Bioscience Holdings Limited (NASDAQ:RGC) Shares? (Simply Wall St.)
Sep-10-21 06:18AM	Cineworld to pay £122m to dissenting shareholders after Regal takeover (The Independent)
02:42AM	UPDATE 1-Cineworld pays $170 mln to Regal investors unhappy with 2017 buyout (Reuters)
Sep-02-21 08:00AM	Regencell Bioscience Holdings Limited Establishes a Joint Venture to Offer COVID Treatment (Business Wire)
Aug-20-21 08:00AM	Regencell Bioscience Holdings Limited Announces Partial Exercise of Underwriters Over-Allotment Option (Business Wire) +204.13%
Aug-05-21 08:00AM	Regencell Bioscience Holdings Limited Releases CEO Letter to Shareholders (Business Wire) +6.29%
Jul-20-21 04:05PM	Regencell Bioscience Holdings Limited Announces Closing of Initial Public Offering (Business Wire)
Jul-16-21 11:43AM	Regencell Bioscience Holdings Limited Announces Pricing of Approximately $21.9 Million Initial Public Offering (Business Wire)

Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. It seeks the treatment of neurocognitive disorders and degeneration, specifically attention deficit hyperactivity disorder and autism spectrum disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Regencell Bioscience Holdings Ltd

Upgrade your FINVIZ experience